26 September, 2018EMA gives a positive opinion to Gilenya, from Novartis, for minors with multiple sclerosisSource: actasanitaria.com The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of the drug Gilenya (fingolimod), […]